Comment on 'Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder' by Wobser et al

Br J Dermatol. 2024 Dec 13:ljae487. doi: 10.1093/bjd/ljae487. Online ahead of print.

Baptiste Louveau^{1

2}, Fanélie Jouenne^{1

2}, Caroline Ram-Wolff^{2

3}, Maxence Mancini¹, Adèle De Masson^{2

3}, Samia Mourah^{1

2}, Maxime Battistella^{2

4}

¹ Department of Pharmacology and Tumor Genomics, DMU BioGeM, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
² Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immu-notherapy (HIPI), Paris, France.
³ Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁴ Department of Pathology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.

No abstract available